Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studiesMay 15, 2023Dermatology
Controlled hyperthermia: Novel treatment of BCCs without surgery continues to be refinedMay 5, 2023DermatologyOncology
